Dulaglutide
Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes
Company n/r · Phase 3 · Completed · Enrollment 150
| Arm | Nausea | Vomiting | Diarrhea | Discontinuation | Deaths |
|---|---|---|---|---|---|
| Dulaglutide Group | n/r | n/r | n/r | n/r | n/r |
| Semaglutide Group | n/r | n/r | n/r | n/r | n/r |
| Tirzepatide Group | n/r | n/r | n/r | n/r | n/r |
A count stays a count. This page does not turn a count into a percent.